The global esophageal cancer market is forecast to grow from USD 6.2 billion in 2023 to USD 11.1 billion by 2031, at a compound annual growth rate (CAGR) of 7.5% during the forecast period. This ...
Global Cancer Monoclonal Antibodies Market Soars with 14%+ CAGR, US and Japan Lead Innovation
The Cancer Monoclonal Antibodies (mAbs) market sector is undergoing a major transformation, fueled b...